Table 3.

Basic characteristics of 2 CML-specific PRO instruments

QuestionnaireConstruct being measuredOverall number of itemsSpecific domains measuredScoring and interpretation
EORTC QLQ-CML2430  (to be used in conjunction with the EORTC QLQ-C30) QoL in patients with CML 54 (including the EORTC QLQ-C30) Impact on daily life; impact on worry/mood; body-image problems; symptom burden (abdominal pain or cramps, dry mouth, skin problems, headache, aches in muscles or joints, hair loss, sweating excessively, heartburn, drowsiness, swelling/edema, urinate frequently, problems with eyes, muscle cramps); satisfaction with care and information; and satisfaction with social life Score ranges between 0 and 100 for all scales, with higher scores indicating worse outcomes, except for satisfaction with care and information and satisfaction with social life, where higher scores indicate better outcome 
MDASI CML31  Symptom burden in patients with CML 26 Symptom severity (pain, fatigue, nausea, sleep, distress, shortness of breath, lack of appetite, drowsiness, dry mouth, sadness, vomiting, difficulty numbness/tingling, edema, rush, muscle soreness or cramping, bruising, malaise, headache); impact of symptoms on daily functioning Score ranges between 0 and 10, with higher scores indicating increased symptom burden 
QuestionnaireConstruct being measuredOverall number of itemsSpecific domains measuredScoring and interpretation
EORTC QLQ-CML2430  (to be used in conjunction with the EORTC QLQ-C30) QoL in patients with CML 54 (including the EORTC QLQ-C30) Impact on daily life; impact on worry/mood; body-image problems; symptom burden (abdominal pain or cramps, dry mouth, skin problems, headache, aches in muscles or joints, hair loss, sweating excessively, heartburn, drowsiness, swelling/edema, urinate frequently, problems with eyes, muscle cramps); satisfaction with care and information; and satisfaction with social life Score ranges between 0 and 100 for all scales, with higher scores indicating worse outcomes, except for satisfaction with care and information and satisfaction with social life, where higher scores indicate better outcome 
MDASI CML31  Symptom burden in patients with CML 26 Symptom severity (pain, fatigue, nausea, sleep, distress, shortness of breath, lack of appetite, drowsiness, dry mouth, sadness, vomiting, difficulty numbness/tingling, edema, rush, muscle soreness or cramping, bruising, malaise, headache); impact of symptoms on daily functioning Score ranges between 0 and 10, with higher scores indicating increased symptom burden 

EORTC QLQ-CML24, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Chronic Myeloid Leukemia 24; EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; MDASI-CML, MD Anderson Symptom Inventory Chronic Myeloid Leukemia Module.

Close Modal

or Create an Account

Close Modal
Close Modal